Skip to main content

Table 3 Ophthalmic history: NVG patients treated with a glaucoma GDD

From: The influence of etiology on surgical outcomes in neovascular glaucoma

  ALL n PDR n RVO n Other n
VA at presentation (Log Mar) 1.61 (SD: 0.73) 120 1.66 (SD: 0.73) 74 1.45 (SD: 0.75) 28 1.68 (SD: 0.71) 18
IOP at presentation (mmHg) 43.7 (SD: 13.5) 120 44.5 (SD:13.7) 74 42.4 (SD: 10.5) 28 42.5 (SD: 16.9) 18
Age at presentation (years)a 66.9 (SD: 11.7) 120 58.2 (SD: 8.8) 74 72.4 (SD: 11.7) 28 65.4 (SD: 12.4) 18
Non-neovascular Glaucoma before presentation 30 (25%) 119 13 (17.6%) 73 10 (35.7%) 28 7 (38.9%) 18
Lens Status at presentation
 Phakic 53 (48%) 110 36 (52.9%) 68 11 (45.8%) 24 6 (33.3%) 18
 Pseudophakic 55 (50%) 110 31 (45.6%) 68 13 (54.2%) 24 11 (61.1%) 18
 Aphakic 2 (1.8%) 110 1 (1.5%) 68 0 (0%) 24 1 (5.6%) 18
Intravitreal injection before presentation 48 (44.9%) 107 56 (75.7%) 64 21 (75%) 25 10 (55.6%) 18
Intravitreal injection at presentation 69 (53.5%) 120 44 (58.7%) 74 17 (54.8%) 28 8 (34.8%) 18
Panretinal photocoagulation before presentation 67 (55.8%) 120 48 (64.9%) 74 10 (35.7%) 28 9 (50%) 18
Panretinal photocoagulation at presentation 19 (14.7%) 120 14 (18.7%) 74 2 (7.1%) 28 3 (16.7%) 18
On no glaucoma meds at presentation 58 (48.33%) 120 41 (55.4%) 74 11 (39.3%) 28 6 (33.3%) 18
Afferent pupillary defect (APD) at presentation 9 (22%) 41 3 (15.8%) 19 4 (30.8%) 13 2 (22.2%) 9
Hyphema at presentation 20 (17%) 118 11 (14.9%) 74 5 (18.5%) 27 4 (23.5%) 17
Vitreous Heme at presentation 22 (22%) 99 16 (22.5%) 59 3 (11.1%) 25 3 (17.7%) 15
Retinal detachment at presentation 7 (7.1%) 99 7 (11.7%) 60 0 (0%) 22 2 (11.1%) 17
  1. aStatistically significant age difference for PDR relative to RVO (p = < 0.001) and Other (p = 0.012)
  2. Note: Continuous variables are presented with standard deviations (SD) and evaluated using the Kruskal-Wallis test. Categorical variables are presented with percentages (%) and evaluated using chi-square, exact chi-square, and the Jonckheere-Terpstra test